Drug Profile
Pegylated glucagon-like peptide 1 - Bio-Ker
Alternative Names: Peglyated GLP1 - Bio-KerLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Bio-Ker
- Class Glucagon-like peptides
- Mechanism of Action Glucagon like peptide 1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in Italy (Parenteral)
- 07 Oct 2011 Pegylated glucagon-like peptide 1 - Bio-Ker is available for licensing as of 07 Oct 2011. http://www.multimedica.it